Loading stock data…
$21.88-0.05 (-0.23%)
OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally.
OrthoPediatrics Corp. in the Healthcare sector is trading at $21.88 with a market capitalization of $648M. Wall Street consensus targets $27.22 (9 analysts), implying a +24.4% move over the next 12 months. The stock is currently 18% below its 52-week high of $26.74, remaining 14.3% above its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality. The Whystock Score of 75/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $70.51M↑ | $59.36M↓ | $61.60M↑ | $61.25M↑ | $61.08M |
| Gross Profit | $52.37M↑ | $43.39M↓ | $45.11M↓ | $45.27M↑ | $44.02M |
| Operating Income | -$4.07M↑ | -$8.34M↓ | -$5.51M↓ | -$4.87M↑ | -$7.69M |
| Net Income | -$7.16M↑ | -$10.69M↓ | -$10.10M↑ | -$11.77M↓ | -$7.11M |
OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. ...